Literature DB >> 34855075

Expression of Circulating Rennin-Angiotensin-Aldosterone-Related microRNAs in Patients with Thyrotoxic Heart Disease.

H M Li1,2, Y X Chen3, X M Fan1, L L Chen2.   

Abstract

Thyrotoxic heart disease (THD) is a common and severe complication of hyperthyroidism and the etiology of this complication remains poorly understood. Activation of the rennin-angiotensin- aldosterone system by excess thyroxin is one of the major factors that contribute to the pathogenesis of THD. Several microRNAs such as miR-21, miR-155, miR-208a, and miR-499 are closely related to the rennin-angiotensin-aldosterone system and therefore should be involved in this process. Our study intends to explore whether these miRNAs are involved in the pathogenesis of THD, and if these miRNAs could be secreted into the circulation and serve as sentinel indicators for THD. Though there is a trend of elevation of miR- 155 in THD than in simple hyperthyroidism patients, we did not find statistically significant differences in the expression of these miRNAs in the blood of THD patients, but we found that miR-155 was significantly up-regulated in patients with Graves' disease with or without THD in comparison with healthy controls. Thus, miR-155 can serve as a novel biomarker for Graves' disease and can play important roles in pathogenesis of Graves' disease.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  miR-155; microRNA; rennin—angiotensin—aldosterone system; thyrotoxic heart disease

Mesh:

Substances:

Year:  2021        PMID: 34855075     DOI: 10.1007/s10517-021-05348-4

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  14 in total

1.  Intraindividual variation of microRNA expression levels in plasma and peripheral blood mononuclear cells and the associations of these levels with the pathogenesis of autoimmune thyroid diseases.

Authors:  Hiroshi Otsu; Mikio Watanabe; Naoya Inoue; Ryota Masutani; Yoshinori Iwatani
Journal:  Clin Chem Lab Med       Date:  2017-05-01       Impact factor: 3.694

2.  AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.

Authors:  Ana Paula Cremasco Takano; Nathalia Senger; Carolina Demarchi Munhoz; Maria Luiza Morais Barreto-Chaves
Journal:  Pflugers Arch       Date:  2017-11-25       Impact factor: 3.657

3.  MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone.

Authors:  Gabriela Placoná Diniz; Caroline Antunes Lino; Camila Rodrigues Moreno; Nathalia Senger; Maria Luiza Morais Barreto-Chaves
Journal:  J Cell Physiol       Date:  2017-03-28       Impact factor: 6.384

4.  A MicroRNA Signature for Evaluation of Risk and Severity of Autoimmune Thyroid Diseases.

Authors:  Rebeca Martínez-Hernández; Miguel Sampedro-Núñez; Ana Serrano-Somavilla; Ana M Ramos-Leví; Hortensia de la Fuente; Juan Carlos Triviño; Ancor Sanz-García; Francisco Sánchez-Madrid; Mónica Marazuela
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

5.  MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.

Authors:  Gabriela Placoná Diniz; Ana Paula Takano; Maria Luiza Morais Barreto-Chaves
Journal:  Mol Cell Endocrinol       Date:  2013-04-26       Impact factor: 4.102

6.  Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation.

Authors:  M S Carneiro-Ramos; G P Diniz; A P Nadu; J Almeida; R L P Vieira; R A S Santos; M L M Barreto-Chaves
Journal:  Basic Res Cardiol       Date:  2010-02-14       Impact factor: 17.165

Review 7.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 8.  Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review.

Authors:  Rokas Navickas; Diane Gal; Aleksandras Laucevičius; Agnė Taparauskaitė; Monika Zdanytė; Paul Holvoet
Journal:  Cardiovasc Res       Date:  2016-06-29       Impact factor: 10.787

9.  Activation of the STAT3/microRNA-21 pathway participates in angiotensin II-induced angiogenesis.

Authors:  Li-Yuan Chen; Xue Wang; Xiao-Long Qu; Li-Na Pan; Ze-Yang Wang; Yong-Hui Lu; Hou-Yuan Hu
Journal:  J Cell Physiol       Date:  2019-04-04       Impact factor: 6.384

10.  Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy.

Authors:  Kaijun Li; Yi Du; Ben-Li Jiang; Jian-Feng He
Journal:  Med Sci Monit       Date:  2014-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.